Mohammed Aliyu Usman, Fadilat Isah Usman, Muhammad Sani Abubakar, Abdulmalik Abdullahi Salman, Auwal Adamu, Mohammed Auwal Ibrahim
Experimental parasitology 2021 MayThe quest for the development of a novel antimalarial drug informed the decision to subject phytol to in vivo trials following a demonstration of therapeutic potential against chloroquine sensitive strain of Plasmodium falciparum under in vitro condition. On this basis, the in vivo anti-Plasmodium berghei activity of phytol including the ameliorative effects of the compound on P. berghei-associated anaemia and organ damage were investigated. Mice were infected with chloroquine-sensitive strain of P. berghei and were treated with phytol at a dose of 10 and 20 mg/kg body weight (BW) for four days. The levels of parasitemia, packed cell volume and redox sensitive biomarkers of liver, brain and spleen tissues were determined. Our result revealed that phytol significantly (p < 0.05) suppressed the multiplication of P. berghei in a dose-dependent manner. Additionally, the phytol significantly (p < 0.05) ameliorated the P. berghei-induced anaemia and brain damage. Data from the present study demonstrated that phytol has suppressive effect on P. berghei and could ameliorate some P. berghei-induced pathological changes. Copyright © 2021 Elsevier Inc. All rights reserved.
Mohammed Aliyu Usman, Fadilat Isah Usman, Muhammad Sani Abubakar, Abdulmalik Abdullahi Salman, Auwal Adamu, Mohammed Auwal Ibrahim. Phytol suppresses parasitemia and ameliorates anaemia and oxidative brain damage in mice infected with Plasmodium berghei. Experimental parasitology. 2021 May;224:108097
PMID: 33736972
View Full Text